首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1535660

非處方乾眼藥水市場 - 按產品類型（防腐劑、不含防腐劑）、類型（品牌、學名藥）、黏度（低、高）、配銷通路（線上藥房、零售藥房） - 全球預測（2024 - 2032）

OTC Dry Eye Drops Market - By Product Type (Preservative, Preservative-free), Type (Branded, Generics), Viscosity (Low, High), Distribution Channel (Online Pharmacies, Retail Pharmacies) - Global Forecast (2024 - 2032)

出版日期: 2024年06月12日 | 出版商:

Global Market Insights Inc. | 英文 195 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2024 年至 2032 年間，非處方乾眼藥水市場的複合年成長率將達到 7.6%，主要是由於乾眼症發病率上升所致。人口老化和螢幕時間延長導致眼部疾病病例增加，從而增加了對非處方藥的需求。根據美國眼科學會2022年的研究，近1,600萬美國人患有乾眼症，而且這種症候群在老年人中更為普遍。

人們對非處方乾眼藥水的偏好激增，尤其是那些尋求快速緩解眼睛刺激等症狀的人，這些症狀通常與長時間接觸數位螢幕和環境污染物有關。此外，產品創新和技術進步也在擴大市場佔有率。製造商正在推出具有更高功效、更持久的緩解效果和更少副作用的配方。不含防腐劑和低過敏性選擇的出現正在擴大產品的吸引力。消費者對眼睛健康的意識不斷增強，加上產品系列多樣化，將塑造產業前景。

整個非處方乾眼藥水市場根據產品類型、類型、黏度、配銷通路和地區進行細分。

無防腐劑市場的需求量大，這主要是由於消費者對眼睛健康的認知和敏感度不斷提高。眼藥水中的防腐劑雖然能有效防止細菌生長，但有時會加劇乾燥和刺激，特別是對於眼睛敏感或需要經常使用的人。不含防腐劑的配方提供了更安全的替代方案，降低了額外刺激的風險，並使它們更適合經常使用。個人化和溫和的眼部護理解決方案的更廣泛趨勢將有利於該細分市場的成長。

由於與品牌藥物相比，學名藥具有成本效益和可及性，預計到 2032 年將佔據顯著的市場佔有率。學名藥產品的功效和安全性與其品牌同類產品相似，但價格較低。隨著醫療保健成本的上升和消費者尋求更實惠的治療選擇，學名藥提供了實用的解決方案，同時又不影響品質。此外，自我藥療的趨勢不斷成長，以及零售和線上通路中學名藥的供應不斷增加，也導致其越來越受歡迎。

到 2032 年，由於人們對眼睛健康的認知不斷提高、乾眼症發病率上升以及醫療保健產品的獲取範圍擴大，拉丁美洲的非處方乾眼藥水行業規模將大幅擴張。巴西和墨西哥等國家的經濟改善導致可支配收入增加，使更多消費者能夠負擔得起眼部護理產品。此外，快速的城市化以及由此導致的人口螢幕時間的增加加劇了乾眼症狀，從而增加了對有效非處方藥解決方案的需求。分銷網路的增強和國際品牌的進入，使該地區的消費者可以輕鬆獲得更廣泛的產品，從而促進了該地區市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 乾眼症盛行率上升
  - 提高意識和自我保健實踐
  - 增加螢幕時間和數位裝置的使用
  - 產品配方的技術進步
- 產業陷阱與挑戰
  - 副作用和過敏反應
  - 替代治療的可用性
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
2023 年定價分析
- 按地區
- 按關鍵人物
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032 年

主要趨勢
防腐劑
不含防腐劑

第 6 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
品牌化
泛型

第 7 章：市場估計與預測：按黏度分類，2021 - 2032 年

主要趨勢
低黏度
高黏度

第 8 章：市場估計與預測：按配銷通路分類，2021 - 2032 年

主要趨勢
網路藥局
零售藥局
其他分銷管道

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

AbbVie, Inc.
Alcon
Allergan plc
Altaire Pharmaceutical Inc.
Bausch Health Companies Inc.
IDEX CORPORATION
Johnson & Johnson
Medicom Healthcare Pvt Ltd.
Novartis AG
OASIS
Prestige Consumer Healthcare Inc.
Rohto Pharmaceutical Co., Ltd.
Similasan Corporation
Sentiss Pharma Private Limited

簡介目錄

Product Code: 9823

The OTC dry eye drops market is anticipated to record 7.6% CAGR between 2024 and 2032, primarily driven by the rising incidence of dry eye disease. Aging populations and prolonged screen time is leading to an increase in eye condition cases, bolstering the demand for over-the-counter remedies. As per a study by the American Academy of Ophthalmology in 2022, nearly 16 million Americans suffer from dry eye disease, and this syndrome is found to be more prevalent in the elderly.

There is a surge in preference for OTC dry eye drops, especially among those seeking quick relief from symptoms like eye irritation, often linked to extended digital screen exposure and environmental pollutants. Further, product innovation and technological advancements are also expanding the market share. Manufacturers are introducing formulations with heightened efficacy, longer-lasting relief, and fewer side effects. The advent of preservative-free and hypoallergenic options is broadening the product appeal. The growing consumer awareness regarding eye health, in tandem with availability of diverse product range, will shape the industry outlook.

The overall OTC dry eye drops market is segmented based on product type, type, viscosity, distribution channel, and region.

The preservative-free segment is witnessing high demand, primarily due to increasing consumer awareness and sensitivity regarding eye health. Preservatives in eye drops, while effective at preventing bacterial growth, can sometimes exacerbate dryness and irritation, especially in individuals with sensitive eyes or those requiring frequent use. Preservative-free formulations offer a safer alternative, reducing the risk of additional irritation and making them more suitable for regular use. The broader trend towards personalized and gentle eye care solutions will favor the segment growth.

The generic segment is slated to hold a notable market share by 2032, due to their cost-effectiveness and accessibility compared to branded counterparts. Generic products offer similar efficacy and safety profiles as their branded equivalents but at a lower price point. As healthcare costs rise and consumers seek more affordable treatment options, generics provide a practical solution without compromising on quality. Additionally, the growing trend towards self-medication and the increasing availability of generics in retail and online channels contribute to their rising popularity.

OTC dry eye drops industry size in Latin America will expand at a significant pace through 2032, driven by increasing awareness about eye health, rising incidences of dry eye syndrome, and expanding access to healthcare products. Economic improvements in countries like Brazil and Mexico have led to higher disposable incomes, enabling more consumers to afford eye care products. Furthermore, rapid urbanization and the resulting increase in screen time among the population have exacerbated dry eye symptoms, boosting demand for effective OTC solutions. The enhanced distribution networks and the entry of international brands, making a wider range of products readily available to consumers across the region, are bolstering the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of dry eye syndrome
  - 3.2.1.2 Growing awareness and self-care practices
  - 3.2.1.3 Increased screen time and digital device usage
  - 3.2.1.4 Technological advancements in product formulations
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Side effects and allergic reactions
  - 3.2.2.2 Availability of alternative treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Preservative
5.3 Preservative-free

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Branded
6.3 Generics

Chapter 7 Market Estimates and Forecast, By Viscosity, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Low viscosity
7.3 High viscosity

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Online pharmacies
8.3 Retail pharmacies
8.4 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa